Back

Association of pre-existing cardiovascular disease with administration of fluoropyrimidine chemotherapy in patients with gastrointestinal malignancies

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular disease in special populations - cardio-oncology (1) Cardio-Oncology HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Aderonke Abiodun

Barts Health Trust, London (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Cardiac manifestations in patients with systemic sclerosis
Associate Professor V. Stoickov (Niska Banja, RS)
Abstract Slides Video
Presentation thumbnail
Sodium-glucose cotransporter 2 inhibitor Dapagliflozin reduces systemic H-FABP and monocyte-to-lymphocyte ratio in preclinical models of antracycline induced cardiotoxicity
Doctor N. Maurea (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Patients with non-Hodgkin's lymphoma treated with CAR T-cell therapy are at risk of impaired left ventricular function
Miss E. Polomski (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Fructose exacerbates anthracycline and HER-2 blocking agent mediated cardiotoxicity through NLRP3 and MyD88 mediated pathways: new roles of sweeteners in cardio-oncology
Doctor V. Quagliariello (Naples, IT)
Abstract Slides Video
Presentation thumbnail
The risks of continuing trastuzumab treatment in HER-2 positive breast cancer after the development of asymptomatic left ventricular dysfunction
Doctor M. Dominique Joseph (Port-au-Prince, HT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular disease in special populations - cardio-oncology (1)

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Clinical evaluation and outcome in patients with heart failure receiving chemotherapy with different anti-cancer agents
thumbnail
Congress Presentation
Role of coronary calcium score and epicardial fat in stratifying baseline risk of cardiotoxicity in patients with gastrointestinal tumors
thumbnail
Congress Presentation
Cardioprotective strategies and outcomes in cancer therapy-related cardiac dysfunction: insights from a single-center study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources